Immunoregulatory mechanisms in chagas disease: Modulation of apoptosis in t-cell mediated immune responses

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Chaves, Ana Thereza ^a   de Assis Silva Gomes Estanislau, Juliana ^a,b   Araújo Fiuza, Jacqueline ^a   Carvalho, Andréa Teixeira ^a   Ferreira, Karine Silvestre ^b   Fares, Rafaelle Christine Gomes ^a   Guimarães, Pedro Henrique Gazzinelli ^b   de Souza Fagundes, Elaine Maria ^b   Morato, Maria José ^a   Fujiwara, Ricardo Toshio ^b   da Costa Rocha, Manoel Otávio ^b   Correa Oliveira, Rodrigo ^a,c,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais IncT DT   (Brazil)

^d FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Apoptosis; Caspase family; Chagas disease; Immunoregulation; T lymphocytes; TNF TNFR superfamily; Trypanosoma cruzi

Indexed keywords

ANNEXIN; CASPASE 10; CASPASE 14; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 7; CASPASE 9; DEATH RECEPTOR 3; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; L SELECTIN; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 21; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR A; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR B; UNCLASSIFIED DRUG; CYTOKINE; PARASITE ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CRUZI; UPREGULATION; BLOOD; CARDIOMYOPATHY; CELL PROLIFERATION; COMPLICATION; DRUG EFFECTS; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, PROTOZOAN; APOPTOSIS; CARDIOMYOPATHIES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHAGAS DISEASE; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; L-SELECTIN; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85008485790     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1523-1     Document Type: Article

References (51)

1. World Health Organization. Fact sheet 340. Geneva, Switzerland: World Health Organization; 2012. http://www.who.int. Accessed 29 October 2012.
2. Rocha MO, Ribeiro AL, Teixeira MM. Clinical management of chronic Chagas cardiomyopathy. Front Biosci. 2003;8:e44-54. Review.
3. Rocha MO, Teixeira MM, Ribeiro AL. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther. 2007;5(4):727-43. Review.
4. Dias JC. The indeterminate form of human chronic Chagas' disease A clinical epidemiological review. Rev Soc Bras Med Trop. 1989;22(3):147-56. Review.
5. Pereira IR, Vilar-Pereira G, Silva AA, Moreira OC, Britto C, Sarmento ED, Lannes- Vieira J. Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease. Mediators Inflamm. 2014;2014:798078. doi:10.1155/2014/798078. Epub 2014 Jul 22. PubMed PMID: 25140115, PubMed Central PMCID: PMC4130030.
6. Sousa GR, Gomes JA, Fares RC, Damásio MP, Chaves AT, Ferreira KS, Nunes MC, Medeiros NI, Valente VA, Corrêa-Oliveira R, Rocha MO. Plasma cytokine expression is associated with cardiac morbidity in Chagas disease. PLoS One. 2014;9(3):e87082. doi:10.1371/journal.pone.0087082.eCollection2014. PubMed PMID: 24603474; PubMed Central PMCID: PMC3945957.
7. Gomes JA, Molica AM, Keesen TS, Morato MJ, de Araujo FF, Fares RC, Fiuza JA, Chaves AT, Pinheiro V, Nunes Mdo C, Correa-Oliveira R, da Costa Rocha MO. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease. Hum Immunol. 2014;75(1):20-8. doi:10. 1016/j.humimm.2013.09.009. Epub 2013 Sep 24.
8. Fares RC, Gomes Jde A, Garzoni LR, Waghabi MC, Saraiva RM, Medeiros NI, Oliveira-Prado R, Sangenis LH, Chambela Mda C, de Arájo FF, Teixeira-Carvalho A, Damásio MP, Valente VA, Ferreira KS, Sousa GR, Rocha MO, Correa-Oliveira R. Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease. Infect Immun. 2013; 81(10):3600-8. doi:10.1128/IAI.00153-13. Epub 2013 Jul 15. PubMed PMID: 23856618; PubMed Central PMCID: PMC3811750.
9. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correa-Oliveira R. Type 1chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun. 2005;73(12): 7960-6. PubMed PMID: 16299288; PubMed Central PMCID: PMC1307097.
10. Gomes JA, Campi Azevedo AC, Teixeira Carvalho A, Silveira Lemos D, Vitelli Avelar D, Sathler-Avelar R, Peruhype-Magalhães V, Silvestre KF, Batista MA, Schachnik NC, Correa-Oliveira R, Eloi Santos S, Martins-Filho OA. Impaired phagocytic capacity driven by downregulation of major phagocytosisrelated cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease. Immunobiology. 2012;217(10):1005-16. doi:10.1016/j.imbio. 2012.01.014. Epub2012Jan20.
11. Dutra WO, Menezes CA, Magalhães LM, Gollob KJ. Immunoregulatory networks in human Chagas disease. Parasite Immunol. 2014;36(8):377-87. doi:10.1111/pim.12107. Review. PubMed PMID: 24611805; PubMed Central PMCID: PMC4143493.
12. Dias FC, Medina Tda S, Mendes-Junior CT, Dantas RO, Pissetti CW, Rodrigues Junior V, Dellalibera-Joviliano R, Marin-Neto JA, Gutierrez FR, Moreau P, Silva JS, Donadi EA. Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations. PLoS One. 2013;8(10):e78367. doi:10.1371/journal.pone.0078367. PubMed PMID: 24205212, PubMed Central PMCID: PMC3813449, eCollection 2013.
13. de Araújo FF, Corrêa-Oliveira R, Rocha MO, Chaves AT, Fiuza JA, Fares RC, Ferreira KS, Nunes MC, Keesen TS, Damasio MP, Teixeira-Carvalho A, Gomes JA. Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal alteredcorrelations with disease severity. Immunobiology. 2012;217(8): 768-77. doi:10.1016/j.imbio.2012.04.008. Epub 2012 May 9.
14. Esper L, Utsch L, Soriani FM, Brant F, Esteves Arantes RM, Campos CF, Pinho V, Souza DG, Teixeira MM, Tanowitz HB, Vieira LQ, Machado FS. Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection. Microbes Infect. 2014;16(6):481-90. doi:10.1016/ j.micinf.2014.03.007. Epub 2014 Apr 1.
15. Minoprio P, Itohara S, Heusser C, Tonegawa S, Coutinho A. Immunobiology ofmurine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells. Immunol Rev. 1989;112:183-207. Review.
16. Welsh RM, McNally JM. Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections. Curr Opin Microbiol. 1999;2(4):382-7. Review.
17. Longhi SA, Atienza A, Perez Prados G, Buying A, Balouz V, Buscaglia CA, Santos R, Tasso LM, Bonato R, Chiale P, Pinilla C, Judkowski VA, Gómez KA. Cytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagasó disease cardiomyopathy patients in response to T. cruzi ribosomal P proteins. PLoS Negl Trop Dis. 2014;8(6): e2906. doi:10.1371/journal.pntd.0002906.eCollection2014Jun. PubMed PMID: 24901991; PubMed Central PMCID: PMC4046937.
18. Leguizamón MS, Mocetti E, García Rivello H, Argibay P, Campetella O. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J Infect Dis. 1999;180(4):1398-402.
19. Marañón C, Planelles L, Alonso C, López MC. HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis. Int Immunol. 2000;12(12):168593.
20. DosReis GA, Lopes MF. The importance of apoptosis for immune regulation in Chagas disease. Mem Inst Oswaldo Cruz. 2009;104 Suppl 1:259-62.
21. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagaś disease is due to a Th1-specific immune response. Infect Immun. 2003;71(3):1185-93. PubMed PMID: 12595431, PubMed Central PMCID: PMC148818.
22. Sambrook J, Gething MJ. Protein structure. Chaperones, paperones. Nature. 1989;342(6247):224-5. PubMed PMID: 2572969.
23. DosReis GA, Fonseca ME, Lopes MF. Programmed T-cell death in experimental Chagas disease. Parasitol Today. 1995;11(10):391-4.
24. Lopes MF, DosReis GA. Apoptosis as a cause of T-cell unresponsiveness in experimental Chagas' disease. Braz J Med Biol Res. 1995;28(8):913-8. Review.
25. Lopes MF, Cunha JM, Bezerra FL, Gonzalez MS, Gomes JE, Lapa E, Silva JR, Garcia ES, Dos Reis GA. Trypanosoma cruzi: both chemically induced andtriatomine-derived metacyclic trypomastigotes cause the same immunologicaldisturbances in the infected mammalian host. Exp Parasitol. 1995;80(2):194-204.
26. + T cell death by apoptosis in experimental Chagas' disease. J Immunol. 1995;154(2):744-52.
27. Rodrigues V Jr, Agrelli GS, Leon SC, Silva Teixeira DN, Tostes S Jr, Rocha- Rodrigues DB. Fas/Fas-L expression, apoptosis and low proliferative response are associated with heart failure in patients with chronic Chagas' disease. Microbes Infect. 2008;10(1):29-37. Epub 2007 Oct 2. PubMed PMID: 18078776.
28. Sousa GR, Gomes JA, Fares RC, Damásio MP, Chaves AT, Ferreira KS, Nunes MC, Medeiros NI, Valente VA, Corrêa-Oliveira R, Rocha MO. Plasma cytokine expression is associated with cardiac morbidity in Chagas disease. PLoS One. 2014;9(3):e87082. doi:10.1371/journal.pone.0087082. PubMed PMID: 24603474, PubMed Central PMCID: PMC3945957, eCollection 2014.
29. Giraldo NA, Bolaños NI, Cuellar A, Roa N, Cucunubá Z, Rosas F, Velasco V, Puerta CJ, Gonźlez JM. T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3?. PLoS Negl Trop Dis. 2013;7(1):e2038. doi:10.1371/journal.pntd. 0002038. PubMed PMID: 23383358, PubMed Central PMCID: PMC3561132, Epub 2013 Jan 31.
30. Kierszenbaum F, Cuna WR, Beltz LA, Sztein MB. Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells. J Immunol. 1990;144(10):4000.
31. Mosca W, Briceño L, Hernández MI. Cell mediated immunity in Chagas' disease. Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells. Mem Inst Oswaldo Cruz. 1991; 86(2):147-52.
32. Maleckar JR, Kierszenbaum F. Variations in cell-mediated immunity to Trypanosoma cruzi during experimental Chagas' disease. Ann Trop Med Parasitol. 1983;77(3):247-54.
33. Argüello RJ, Albareda MC, Alvarez MG, Bertocchi G, Armenti AH, Vigliano C, Meckert PC, Tarleton RL, Laucella SA. Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease. PLoS One. 2012;7(5):e35966. doi:10.1371/journal. pone.0035966. PubMed PMID: 22574131, PubMed Central PMCID: PMC3344843, Epub 2012 May 4.
34. Azuma M, Phillips JH, Lanier LL. CD28- T lymphocytes. Antigenic and functional properties. J Immunol. 1993;150(4):1147-59.
35. Ritprajak P, Azuma M. Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma. Oral Oncol. 2015;51(3):221-8. doi:10.1016/j.oraloncology. 2014.11.014. Epub 2014 Dec 12. Review.
36. +)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes Infect. 2001;3(12):971-84.
37. Tostes Jr S, Bertulucci Rocha-Rodrigues D, de Araujo PG, Rodrigues Jr V. Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. Int J Cardiol. 2005;99(2):233-7.
38. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P. Myocardial cell death in human diabetes. Circ Res. 2000;87(12): 1123-32.
39. Feuerstein GZ. Apoptosis in cardiac diseases-new opportunities for novel therapeutics for heart diseases. Cardiovasc Drugs Ther. 1999;13(4):289-94. Review.
40. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336(16):1131-41.
41. Zhang J, Andrade ZA, Yu ZX, Andrade SG, Takeda K, Sadirgursky M, Ferrans VJ. Apoptosis in a canine model of acute Chagasic myocarditis. J Mol Cell Cardiol. 1999;31(3):581-96.
42. de Souza EM, Araújo-Jorge TC, Bailly C, Lansiaux A, Batista MM, Oliveira GM, Soeiro MN. Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res. 2003;314(2):223-35. Epub 2003 Aug 20.
43. De Souza EM, Nefertiti AS, Bailly C, Lansiaux A, Soeiro MN. Differential apoptosis-like cell death in amastigote and trypomastigote forms from Trypanosoma cruzi-infected heart cells in vitro. Cell Tissue Res. 2010;341(1): 173-80. doi:10.1007/s00441-010-0985-5. Epub 2010 May 22.
44. Castro-Sesquen YE, Gilman RH, Paico H, Yauri V, Angulo N, Ccopa F, Bern C. Cell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruzi. PLoS Negl Trop Dis. 2013;7(2):e1996. doi:10.1371/journal.pntd.0001996. PubMed PMID: 23409197, PubMed Central PMCID: PMC3566988, Epub 2013 Feb 7.
45. Rodrigues Jr V, Agrelli GS, Leon SC, Silva Teixeira DN, Tostes Jr S, Rocha-Rodrigues DB. Fas/Fas-L expression, apoptosis and low proliferative response are associated with heart failure in patients with chronic Chagas' disease. Microbes Infect. 2008; 10(1):29-37. Epub 2007 Oct 2.
46. + T lymphocytes from infected hosts. J Immunol. 1998;160(3):1313-9.
47. Henriques Pons A, Oliveira GM, Paiva MM, Correa AF, Batista MM, Bisaggio RC, Liu CC, Cotta-De-Almeida V, Coutinho CM, Persechini PM, Araujo-Jorge TC. Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection. Int J Exp Pathol. 2002;83(2): 67-79. PubMed PMID: 12084043; PubMed Central PMCID: PMC2517672.
48. Lula JF, Rocha MO, Nunes Mdo C, Ribeiro AL, Teixeira MM, Bahia MT, Talvani A. Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction. Eur J Heart Fail. 2009;11(9):825-31. doi:10.1093/eurjhf/hfp105. Epub 2009 Aug 4.
49. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz. 2003;98(3):407-11. Epub 2003 Jul 18.
50. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis. 2004;38(7):943-50. Epub 2004 Mar 10. PubMed PMID: 15034825.
51. Elzey BD, Griffith TS, Herndon JM, Barreiro R, Tschopp J, Ferguson TA. Regulation of Fas ligand-induced apoptosis by TNF. J Immunol. 2001;167(6):3049-56.